Literature DB >> 3907605

Distribution of gentamicin by immunofluorescence in the guinea pig inner ear.

T Hayashida, Y Nomura, M Iwamori, Y Nagai, T Kurata.   

Abstract

We studied the distribution of gentamicin in the inner ear, brain and kidney of the guinea pig following intraperitoneal administration or perfusion of gentamicin through the perilymphatic space. The resulting histopathological changes were examined by immunofluorescence using antigentamicin antiserum. After perfusion of gentamicin through the perilymphatic space, specific fluorescence was found in the cochlea, and was especially prominent in the outer hair cells, basilar membrane and basilar crest. Although no fluorescence was observed in the cochlea following intraperitoneal administration of high doses of gentamicin, type I hair cells in the vestibule were seen to be selectively stained with the antibody. Furthermore, some of the vestibular ganglion cells, Purkinje cells and unidentified nuclei in the brain stem were also stained. In particular, fine granules showing relatively intense fluorescence were recognized in the cytoplasm of the stained cells. In the cortex of kidney, only proximal tubular cells were stained with intense fluorescence. Our results suggest that the aminoglycoside antibiotics have two sites of action: one is the cell membrane of the sensory hair cells and the other is the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907605     DOI: 10.1007/bf00453548

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  11 in total

1.  The vestibular sensory epithelia in the cat labyrinth and their reactions in chronic streptomycin intoxication.

Authors:  J WERSALL; J E HAWKINS
Journal:  Acta Otolaryngol       Date:  1962-01       Impact factor: 1.494

2.  Effect of neomycin on phosphoinositide labelling and calcium binding in guinea-pig inner ear tissues in vivo and in vitro.

Authors:  A Orsulakova; E Stockhorst; J Schacht
Journal:  J Neurochem       Date:  1976-02       Impact factor: 5.372

3.  An experimental study of the toxic effects of streptomycin on the vestibular apparatus of the cat; the central nervous system.

Authors:  J WINSTON; F H LEWEY
Journal:  Ann Otol Rhinol Laryngol       Date:  1948-09       Impact factor: 1.547

4.  Action of neomycin on the metabolism of polyphosphoinositides in the guinea pig kidney.

Authors:  A Schibeci; J Schacht
Journal:  Biochem Pharmacol       Date:  1977-10-01       Impact factor: 5.858

5.  The toxic effect of streptomycin on the eighth cranial nerve; histological investigations; a preliminary report.

Authors:  K BERG
Journal:  Ann Otol Rhinol Laryngol       Date:  1949-06       Impact factor: 1.547

6.  Radioactive labeling of phospholipids and proteins by cochlear perfusion in the guinea pig and the effect of neomycin.

Authors:  E Stockhorst; J Schacht
Journal:  Acta Otolaryngol       Date:  1977 May-Jun       Impact factor: 1.494

7.  Effects of perilymphatic perfusion with neomycin on the cochlear microphonic potential in the guinea pig.

Authors:  A L Nuttall; D M Marques; M Lawrence
Journal:  Acta Otolaryngol       Date:  1977 May-Jun       Impact factor: 1.494

8.  Improved conditions for the preservation and extraction of polyphosphoinositides.

Authors:  G Hauser; J Eichberg
Journal:  Biochim Biophys Acta       Date:  1973-11-29

9.  Observation of click-evoked compound VIII nerve responses before, during, and over seven months after kanamycin treatment in the guinea pig.

Authors:  J M Aran; J Darrouzet
Journal:  Acta Otolaryngol       Date:  1975 Jan-Feb       Impact factor: 1.494

10.  Effect of osmotic blood-brain barrier disruption on gentamicin penetration into the cerebrospinal fluid and brains of normal rabbits.

Authors:  L J Strausbaugh; G S Brinker
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

View more
  11 in total

1.  Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.

Authors:  Hyejeong Hong; Kelly E Dooley; Laura E Starbird; Howard W Francis; Jason E Farley
Journal:  Arch Toxicol       Date:  2019-04-08       Impact factor: 5.153

2.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

3.  An immunohistochemical method for the study of aminoglycoside ototoxicity in the guinea pig cochlea using decalcified frozen sections.

Authors:  T Hayashida
Journal:  Arch Otorhinolaryngol       Date:  1989

4.  Temporal and spatial distribution of gentamicin in the peripheral vestibular system after transtympanic administration in guinea pigs.

Authors:  Ru Zhang; Yi-Bo Zhang; Chun-Fu Dai; Peter S Steyger
Journal:  Hear Res       Date:  2013-02-01       Impact factor: 3.208

5.  Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

Authors:  S K Moestrup; S Cui; H Vorum; C Bregengård; S E Bjørn; K Norris; J Gliemann; E I Christensen
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Transtympanic administration of aminoglycosides in patients with Menière's disease.

Authors:  T Sala
Journal:  Arch Otorhinolaryngol       Date:  1988

7.  Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration.

Authors:  Sofia Lyford-Pike; Casey Vogelheim; Eugene Chu; Charles C Della Santina; John P Carey
Journal:  J Assoc Res Otolaryngol       Date:  2007-09-25

8.  Gentamicin-induced alterations of succinic dehydrogenase activity in the organ of Corti as revealed by non-decalcified frozen sections of the guinea pig's cochlea.

Authors:  F S Yang; J S Han
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

9.  Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration.

Authors:  A R Beaubien; E Ormsby; A Bayne; K Carrier; G Crossfield; M Downes; R Henri; M Hodgen
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 10.  What is the evidence for once-daily aminoglycoside therapy?

Authors:  M L Barclay; E J Begg; K G Hickling
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.